Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)
Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate whether oral sodium bicarbonate supplementation to
ensure a constant bicarbonate profile in haemodialysis patients will primarily lower
predialysis potassium levels and secondary lead to improvements in cardiac function, muscle
mass and dialysis related symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Imperial College Healthcare NHS Trust
Collaborator:
National Institute for Health Research, United Kingdom